Intracerebroventricular administration of quinolinic acid induces a selective decrease of inositol(1,4,5)-trisphosphate receptor in rat brain

Neurochemistry International

Volumn 33, Issue 2, 1998, Pages 109-119

  Haug, Lise Sofie ^a   Østvold, Anne Carine ^a   Torgner, Ingeborg ^a   Roberg, Bjørg ^a   Dvořáková, Lenka ^b   Št'astný, František ^b   Walaas, S Ivar ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Calcium homeostasis; Excitotoxicity; IP3 receptor; Neurodegeneration; Phosphate activated glutaminase; Quinolinic acid

Indexed keywords

ANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMINASE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PHOSPHOPROTEIN; PHOSPHOPROTEIN DARPP 32; QUINOLINIC ACID; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN TISSUE; CELL LOSS; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; ENTORHINAL CORTEX; HIPPOCAMPUS; HUNTINGTON CHOREA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NEOSTRIATUM; NERVE CELL; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR BINDING;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; CALCIUM CHANNELS; CORPUS STRIATUM; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMINASE; INJECTIONS, INTRAVENTRICULAR; INOSITOL 1,4,5-TRISPHOSPHATE; MALE; NERVE TISSUE PROTEINS; NEURONS; PHOSPHOPROTEINS; QUINOLINIC ACID; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SYNAPTOPHYSIN; TRITIUM;

EID: 0032143943     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(98)00021-7     Document Type: Article

References (77)

1. Alavez, S., Gutiérrez-Kobeh, L., Morán, J., 1996. Characterization of the activation of glutaminase induced by N-methyl-D-aspartate and potassium in cerebellar granule cells. J. Neurosci. Res. 45, 637-646.
2. Aoki, C., Kaneko, T., Starr, A., Pickel, V.M., 1991. Identification of mitochondrial and non-mitochondrial glutaminase within select neurons and glia of rat forebrain by electron microscopic immunocytochemistry. J. Neurosci. Res. 28, 531-548.
3. Bakker, M.H., Foster, A.C., 1991. An investigation of the mechanisms of delayed neurodegeneration caused by direct injection of quinolinate into the rat striatum in vivo. Neuroscience 42, 387-395.
4. Bazzett, T.J., Becker, J.B., Kaatz, K.W., Albin, R.L., 1993. Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration. Exp. Neurol. 120, 177-185.
5. Beal, M.F., Kowall, N.W., Ellison, D.W., Mazurek, M.F., Swartz, K.J., Martin, J.B., 1986. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321, 168-171.
6. Berridge, M.J., 1993. Inositol trisphosphate and calcium signalling. Nature 361, 315-325.
7. 3-and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature 351, 751-754.
8. Björklund, H., Olson, L., Dahl, D., Schwarcz, R., 1986. Short-and long-term consequences of intracranial injections of the excitotoxin, quinolinic acid, as evidenced by GFA immunohistochemistry of astrocytes. Brain Res. 371, 267-277.
9. Block, F., Schwarz, M., 1994. Expression of GFAP in the striatum and its projection areas in response to striatal quinolinic acid lesion in rats. Neuro Report 5, 2237-2240.
10. Burton, K., 1956. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62, 315-322.
11. Daniell, L.C., 1991. N-Methyl-D-aspartate increases cytoplasmic free calcium in mouse hippocampus. Neuropharmacology 30, 539-545.
12. Diemer, N.H., Valente, E., Bruhn, T., Berg, M., Jørgensen, M.B., Johansen, F.F., 1993. Glutamate receptor transmission and ischemic nerve cell damage: evidence for involvement of excitotoxic mechanisms. In: Kogure, K., Hossmann, K.-A., Siesjö, B.K. (Eds.). Progress in Brain Research, Vol. 96. pp. 105-123.
13. Dietrich, W.D., Halley, M., Alonso, O., Globus, M.Y.-T., Busto, R., 1992. Intraventricular infusion of N-methyl-D-aspartate. 2. Acute neuronal consequences. Acta Neuropathol. 84, 630-637.
14. Eng, L.F., 1985. Glial fibrillary acidic protein (GFAP): The major protein of glial intermediate filaments in differentiated astrocytes. J. Neuroimmunol. 8, 203-214.
15. Ferrante, R.J., Kowall, N.W., Cipolloni, P.B., Storey, E., Beal, M.F., 1993. Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization. Exp. Neurol. 119, 46-71.
16. Fisher, H.F., 1985. L-glutamate dehydrogenase from bovine liver. Meth. Enzymol. 113, 16-27.
17. Fotuhi, M., Dawson, T.M., Sharp, A.H., Martin, L.J., Graybiel, A.M., Snyder, S.H., 1993. Phosphoinositide second messenger system is enriched in striosomes: immunohistochemical demonstration of inositol 1,4,5-trisphosphate receptors and phospholipase C and in primate basal ganglia. J. Neurosci. 13, 3300-3308.
18. 2+ signaling in the brain. J. Neurochem. 64, 953-960.
19. 4 binding in Alzheimer's disease brain. Brain Res. 681, 160-166.
20. Hajos, F., Kalman, M., Zilles, K., Schleicher, A., Sotonyi, P., 1990. Remote astrocytic response as demonstrated by glial fibrillary acidic protein immunohistochemistry in the visual cortex of dorsal lateral geniculate nucleus lesioned rats. Glia 3, 301-310.
21. Haug, L.S., Østvold, A.C., Cowburn, R.F., Garlind, A., Winblad, B., Bogdanovich, N., Walaas, S.I., 1996a. Decreased inositol (1,4,5)-triphosphate receptor levels in Alzheimer's disease cerebral cortex: selectivity of changes and possible correlation to pathological severity. Neurodegeneration 5, 169-176.
22. 3-receptor and phosphate-activated glutaminase are highly enriched in neurons as compared to glia cells in rat neostriatum. J. Neurochem. 66(Suppl. 2), S59B.
23. 28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease. Neuroscience 65, 397-407.
24. Iverfeldt, K., Walaas, S.I., Greengard, P., 1993. Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration. Proc. Natl. Acad. Sci. USA 90, 4146-4150.
25. 3H]inositoltrisphosphate binding in kainic acid-lesioned and post-ischemic rat hippocampus. Brain Res. 538, 246-250.
26. Joseph, S.K., 1996. The inositol triphosphate receptor family. Cell. Signal. 8, 1-7.
27. Kaneko, T., Mizuno, N., 1992. Mosaic distribution of phosphate-activated glutaminase-like immunoreactivity in the rat striatum. Neuroscience 49, 329-345.
28. Keilhoff, G., Wolf, G., Št'astný, F., Schmidt, W., 1990. Quinolinate neurotoxicity and glutamatergic structures. Neuroscience 34, 235-242.
29. 3H]inositol 1,4,5-triphosphate binding is markedly decreased in human olivopontocerebellar atrophy. Brain Res. 489, 373-376.
30. Kugler, P., 1993. In situ measurements of enzyme activities in the brain. Histochem. J. 25, 329-338.
31. Kvamme, E., 1983. Deaminases and amidases. In: Lajtha, A. (Ed.). Handbook of Neurochemistry, Vol. 4. Plenum Press, New York. pp. 85-110.
32. Laake, J.H., Roberg, B., Takumi, Y., Haug, F.-M., Kvamme, E., Torgner, I., Ottersen, O.P., 1997. Electron microscopy of the subcellular localization of phosphate activated glutaminase - an immunogold investigation in rat cerebellar cortex. Soc. Neurosci. Annual Meeting, New Orleans, La. Oct. 25-30, 1997.
33. Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
34. 2+ pump and calreticulin in gerbil forebrain. J. Neurochem. 66(Suppl. 2), S59C.
35. Levy, L.M., Lehre, K.P., Walaas, S.I., Storm-Mathisen, J., Danbolt, N.C., 1995. Down-regulation of glial glutamate transporters after glutamatergic denervation in the rat brain. Eur. J. Neurosci. 7, 2036-2041.
36. Lisý, V., Dvořáková, L., Št'astný, F., 1994. Altered glutamate binding following quinolinate lesions in developing rat brain. Exp. Neurol. 125, 82-86.
37. Maeda, N., Ninobe, M., Nakahira, K., Mikoshiba, K., 1988. Purification and characterization of P400 protein, a glycoprotein characteristic of Purkinje cell, from mouse cerebellum. J. Neurochem. 51, 1724-1730.
38. 2+-channel. FEBS Lett. 323, 229-232.
39. Matsumoto, M., Nakagawa, T., Inoue, T., Nagata, E., Tanaka, K., Takano, H., Minowa, O., Kuno, J., Sakakibara, S., Yamada, M., Yoneshima, H., Miyawaki, A., Fukuuchi, Y., Furuichi, T., Okano, H., Mikoshiba, K., Noda, T., 1996. Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature 379, 168-171.
40. Mattson, M.P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., Rydel, R.E., 1992. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
41. Mattson, M.P., Furukawa, K., Bruce, A.J., Mark, R.J., Blanc, E., 1996. Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia. In: Wasco, W., Tanzi, R.E. (Eds.). Molecular Mechanisms of Dementia. Humana Press Inc., Totowa, NJ. pp. 103-143.
42. Michalak, M., Milner, R.E., Burns, K., Opas, M., 1992. Calreticulin. Biochem. J. 285, 681-692.
43. 3 receptors. Semin. Cell Biol. 5, 273-281.
44. Nadler, J.V., Perry, B.W., Cotman, C.W., 1978. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature 271, 676-677.
45. O'Callaghan, J.P., 1994. Biochemical analysis of glial fibrillary acidic protein as a quantitative approach to neurotoxicity assessment: advantages, disadvantages and application to the assessment of NMDA receptor antagonist-induced neurotoxicity. Psychopharmacol. Bull. 30, 549-554.
46. Ouimet, C.C., Miller, P.E., Hemmings, Jr., H.C., Walaas, S.I., Greengard, P., 1984. DARPP-32, a dopamine-and adenosine 3′ : 5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J. Neurosci. 4, 111-124.
47. Perez, P., Flores, A., Santamaria, A., Rios, C., Galvan-Arzate, S., 1996. Changes in transitional metal contents in rat brain regions after in vivo quinolinate intrastriatal administration. Arch. Med. Res. 27, 449-452.
48. Roberg, B., Torgner, I. Aa., Kvamme, E., 1995. The orientation of phosphate activated glutaminase in the inner mitochondrial membrane of synaptic and non-synaptic rat brain mitochondria. Neurochem. Int. 27, 367-376.
49. Roberts, R.C., Ahn, A., Swartz, K.J., Beal, M.F., DiFiglia, M., 1993. Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome. Exp. Neurol. 124, 274-282.
50. Ross, C.A., Meldolesi, J., Milner, T.A., Satoh, T., Supattapone, S., Snyder, S.H., 1989. Inositol 1,4,5-trisphosphate receptor localized to endoplasmic reticulum in cerebellar Purkinje neurons. Nature 339, 468-470.
51. Rothe, F., Brosz, M., Storm-Mathisen, J., 1994. Quantitative ultrastructural localization of glutamate dehydrogenase in the rat cerebellar cortex. Neuroscience 62, 1133-1146.
52. Schmidt, W., Wolf, G., Calka, J., Schmidt, H.H., 1995. Evidence for bidirectional changes in nitric oxide synthase activity in the rat striatum after excitotoxically (quinolinic acid) induced degeneration. Neuroscience 67, 345-356.
53. Schousboe, A., Hertz, L., Svenneby, G., Kvamme, E., 1978. Phosphate activated glutaminase activity and glutamine uptake in primary cultures of astrocytes. J. Neurochem. 32, 943-950.
54. Schwarcz, R., Whetsell, Jr., W.O., Mangano, R.M., 1983. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219, 316-318.
55. Shapiro, R.A., Farrell, L., Srinivasan, M., Curthoys, N.P., 1991. Isolation, characterization, and in vitro expression of a cDNA that encodes the kidney isoenzyme of the mitochondrial glutaminase. J. Biol. Chem. 266, 18792-18796.
56. Simpson, P.B., Challiss, R.A.J., Nahorski, S.R., 1994. Chronic activation of muscarinic and metabotropic glutamate receptors down-regulates type I inositol 1,4,5-trisphosphate receptor expression in cerebellar granule cells. J. Neurochem. 63, 2369-2372.
57. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M., Olson, B.J., Klenk, D.C., 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
58. Št'astný, F., Dvořáková, L., Lisý, V., 1997. Biochemical characteristics of γ-glutamyl transpeptidase in capillaries from entorhinohippocampal complex of quinolinate-lesioned rat brain. Molec. Chem. Neuropathol. 32, 143-161.
59. Štípek, S., Št'astný, F., Pláteník, J., Crkovská, J., Zima, T., 1997. The effect of quinolinate on rat brain lipid peroxidation is dependent on iron. Neurochem. Int. 30, 233-237.
60. Stone, T.W., Perkins, M.N., 1981. Quinolinic acid: a potent endogenous excitant at amino acid receptors in rat CNS. Eur. J. Pharmacol. 72, 411-412.
61. Tanaka, C., Nishino, N., Hashimoto, T., Kitamura, N., Yoshihara, C., Saito, N., 1993. Second messenger systems in brains of patients with Parkinson's or Huntington's disease. Adv. Neurol. 60, 175-180.
62. 2+]. J. Cell. Biol. 132, 607-616.
63. Torgner, I.Aa., Roberg, B., Kvamme, E., 1995. Kinetic properties of phosphate activated glutaminase from brain as influenced by membrane binding or solubilization. J. Neurochem. 65(Suppl.), S158A.
64. Towbin, H., Staehelin, T., Gordon, J., 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354.
65. Trump, B.F., Berezesky, I.K., 1995. Calcium-mediated cell injury and cell death. FASEB J. 9, 219-228.
66. 2+ homeostasis before cell death revealed by whole cell recording of ischemic CA1 hippocampal neurons. Neuroscience 49, 807-817.
67. Walaas, I., 1981. Biochemical evidence for overlapping neocortical and allocortical projections to the nucleus accumbens and rostral caudatoputamen in the rat brain. Neuroscience 6, 399-405.
68. Walaas, S.I., Nairn, A.C., Greengard, P., 1983. Regional distribution of calcium-and cyclic adenosine 3′ : 5′-monophosphate-regulated protein phosphorylation systems in mammalian brain. I. Particulate systems. J. Neurosci. 3, 291-301.
69. Walaas, S.I., Greengard, P., 1984. DARPP-32, a dopamine-and adenosine 3′ : 5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain. J. Neurosci. 4, 84-98.
70. r. 260,000. J. Neurosci. 6, 954-961.
71. Walaas, S.I., Jahn, R., Greengard, P., 1988. Quantification of nerve terminal populations: Synaptic vesicle-associated proteins as markers for synaptic density in the rat neostriatum. Synapse 2, 516-520.
72. Walaas, S.I., Wang, J.K.T., Albert, K.A., Greengard, P., 1989. Calcium/diacylglycerol-dependent protein kinase and its major 87-kilodalton protein substrate are differentially distributed in rat basal ganglia. J. Neurochem. 53, 1199-1202.
73. 3H]inositol 1,4,5-trisphosphate binding in Huntington's disease. J. Neurochem. 56, 1417-1422.
74. Wojcikiewicz, R.J.H., Furuichi, T., Nakade, S., Mikoshiba, K., Nahorski, S.R., 1994. Muscarinic receptor activation down-regulates the type I inositol 1,4,5-trisphosphate receptor by accelerating its degradation. J. Biol. Chem. 269, 7963-7969.
75. Wojcikiewicz, R.J.H., Oberdorf, J.A., 1996. Degradation of inositol 1,4,5-trisphosphate receptors during cell stimulation is a specific process mediated by cysteine protease activity. J. Biol. Chem. 271, 16652-16655.
76. 3H]inositol 1,4,5-trisphosphate binding in Alzheimer's disease. Neurosci. Lett. 94, 198-202.
77. 3-3-kinase in rat brain after transient focal cerebral ischemia. Mol. Brain Res. 32, 252-260.